Navigation Links
Nasdaq Stays Suspension of Trading in deCODE Stock
Date:4/28/2009

deCODE shares will continue to trade as usual pending Nasdaq listing review

REYKJAVIK, Iceland, April 28 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) announced that it has this evening received a letter from the Nasdaq Listing and Hearing Review Council stating that the Council has called for review the April 22 determination of the Nasdaq Listing Qualifications Panel regarding the delisting of the company's common stock from the Nasdaq Stock Market. Pending the completion of this review the Council has also stayed the Panel's proposed suspension of trading in deCODE common stock mentioned in deCODE's 8-K filing made after the close of the market this afternoon. The company's stock will therefore continue to trade as usual on the Nasdaq Capital Market during the review process.

About deCODE

deCODE is a biopharmaceutical company developing drugs and DNA-based tests to improve the treatment, diagnosis and prevention of common diseases. Its lead therapeutic programs, which leverage the company's expertise in chemistry and structural biology, include DG041, an antiplatelet compound being developed for the prevention of arterial thrombosis; DG051 and DG031, compounds targeting the leukotriene pathway for the prevention of heart attack; and DG071 and a platform for other PDE4 modulators with therapeutic applications in Alzheimer's disease and other conditions. deCODE is a global leader in human genetics, and has identified key variations in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular disease to cancer. Based upon these discoveries deCODE has brought to market a growing range of DNA-based tests for gauging risk and empowering prevention of common diseases. Through its CLIA-registered laboratory, deCODE offers deCODE T2(TM) for type 2 diabetes; deCODE AF(TM)
'/>"/>

SOURCE deCODE genetics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
3. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
4. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
5. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
6. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
7. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
8. XTL Receives Staff Letter From NASDAQ
9. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
10. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
11. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , , , , , , , ... , AUDIO: , A team of scientists ...rsity of Arizona, Cold Spring Harbor Laboratory an...e DNA of corn. The... , , Click h... , , , , , , , ...
(Date:11/20/2009)... , SAN DIEGO, Nov. 20 Veridiam ...rd in the mid-size company category at the 2009 Wo...d by the San Diego Society for Human Resources Man...uman resources practices. ,, Veridiam was one o...ee-nominated companies, honored at the recent awar...
(Date:11/20/2009)... , ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstC...nced that it has priced an underwritten public off... price to the public of $3.30 per share. The appr...ting the underwriting discounts and commissions, w...rials of our VLP-based vaccines, internal research...
(Date:11/20/2009)... , SEATTLE, Nov. 20 /PRNewswire-FirstCall/ ...CTIC) announced today that the Ninth Circuit Court...nd ruled that CTI should be allowed to pursue all ...case back to the District Court for trial. CTI fi...er third-party reimbursement consultant for CTI,s ...
Breaking Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2
...database of biotech contract service providers, I...tiative to grow the life sciences, has released an... pharmaceutical and biotechnology industries,holdi...e sciences growth.,In addition, the initiative has...adslinx.com -- offering a searchable database of,...
...MBF Healthcare,Acquisition Corp. (Amex: MBH ), a ...y, announced today that it and Critical Homecare,S...g provider of,comprehensive home infusion therapy ...present on Tuesday, March 18, 2008 at the Lehman B...ce in Miami, Florida. On February,6, 2008, MBH sig...
...rmacopeia,(Nasdaq: PCOP ), an innovator in the di...erapeutics, today announced advancements for two m...Vice President, Clinical and,Regulatory Affairs, h...l,and Regulatory Affairs, and the role of S. David...and Preclinical Chemical Development, has been,exp...
Other Biology Technology:BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services 2BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services 3BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services 4MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 2MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 3Pharmacopeia Announces Management Team Changes 2Pharmacopeia Announces Management Team Changes 3Pharmacopeia Announces Management Team Changes 4Pharmacopeia Announces Management Team Changes 5
(Date:11/23/2009)...re a nasty business, posing dangers to human healt...sity is launching a new project with funding from ...t targets the fat and grease that contribute to mi...n planners new tools to further reduce the risk of...anitary" sewer systems, as opposed to "combined" s...
(Date:11/22/2009)...ldren exposed prenatally to tobacco smoke and duri... for ADHD, according to research done at Cincinnat...y estimates that up to 35 percent of ADHD cases in...duced by eliminating both of these environmental e...children , "Tobacco and lead exposure each have...
(Date:11/22/2009)...ted gene deletion can increase the likelihood of i...ntation, an international team of researchers repo...ture Genetics . When the gene, called UGT2B17, is ... recipient,s, transplants have a significantly gre...versus-host disease, in which immune cells from th...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4Americans Attitudes On Economic Issues Have Shifted Per Franklin 26 Marshall College Poll With Hearst Television 58253 1Americans Attitudes On Economic Issues Have Shifted Per Franklin 26 Marshall College Poll With Hearst Television 58253 2Americans Attitudes On Economic Issues Have Shifted Per Franklin 26 Marshall College Poll With Hearst Television 58253 3Americans Attitudes On Economic Issues Have Shifted Per Franklin 26 Marshall College Poll With Hearst Television 58253 4China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 14257 1China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 14257 2China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 14257 3China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS 14257 4Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 1Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 2Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 3Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 4Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 5Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 6Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009 14255 7
...TON Members of the public can send their names ar...ssion dedicated to understanding the effects of pa...y on our climate. , The "Send Your Name Around th... the science mission and place their names in orbi...nts can submit their information, is located at: ,...
..., Sept. 25, 2008 Noted energy and environment exp...ries at the University of Houston, addressing the ...or the Houston area. , "The Science and Policy ... to the public and is held from 5:45 to 7:15 p.m. ...week and is being held in room 101 of the Cameron ...
...er managing environmental issues during deployment... advantages that will help in combat and post-conf..., according to a RAND Corporation study issued tod...ually given environmental concerns high priority d...onditions can have on troop health, safety and sec...
Other Biology News:Send your name around the Earth on NASA'S Glory mission 2Experts discuss climate change during UH lecture series 2Army can boost mission success by better managing 2Army can boost mission success by better managing 3Army can boost mission success by better managing 4
Mouse Anti-Verotoxin II (Shiga-like) A subunit (SLT-2a) Monoclonal Antibody, Unconjugated, Clone 557 from Meridian Life Science, Inc.
...nce luminescent signals and have low background lu... medium binding) polystyrene surface is hydrophobi... interactions,• Is suitable primarily for the...dies, that have large hydrophobic regions that can...
Flp-In T-REx Core Kit from Invitrogen
BD Falcon 1536-well Black/Clear Microplates from BD Biosciences - Discovery Labware
Biology Products: